Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?
- PMID: 38563076
- PMCID: PMC11157998
- DOI: 10.1177/27551938241242602
Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?
Abstract
Cambodia has experienced exponential economic growth in recent years and is expected to graduate from least developed country (LDC) status within the next decade. Membership of the World Trade Organization (WTO) will require Cambodia to grant product and process patents for pharmaceuticals upon LDC graduation. This study aims to measure the impact of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on the price of HIV and hepatitis C medicine in Cambodia once it graduates from LDC status and is obliged to make patents available for pharmaceutical products and processes. Using scenarios based on likely outcomes of accession to the TRIPS Agreement, it measures the impact on the price of the HIV treatment program and compares that impact with the hepatitis C treatment program. Graduation from LDC status would be expected to result in a modest increase in the cost of the antiretroviral (ARV) treatment program and very large increases in the cost of the direct acting antivirals (DAA) treatment program. If annual treatment budgets remain constant, patent protection could see 1,515 fewer people living with HIV able to access ARV treatment and 2,577 fewer people able to access DAA treatment (a drop in treatment coverage of 93%).
Keywords: Cambodia; HIV; TRIPS; antiretroviral; direct acting antiviral; generic; hepatitis C; intellectual property; patent.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.Glob Public Health. 2009;4(6):515-27. doi: 10.1080/17441690902796449. Glob Public Health. 2009. PMID: 19548158
-
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25060. doi: 10.1002/jia2.25060. J Int AIDS Soc. 2018. PMID: 29633580 Free PMC article.
-
[Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].Salud Colect. 2015 Mar;11(1):9-21. doi: 10.18294/sc.2015.412. Salud Colect. 2015. PMID: 25853827 Spanish.
-
What is the impact of intellectual property rules on access to medicines? A systematic review.Global Health. 2022 Apr 15;18(1):40. doi: 10.1186/s12992-022-00826-4. Global Health. 2022. PMID: 35428250 Free PMC article. Review.
-
[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].Cad Saude Publica. 2007 Feb;23(2):257-67. doi: 10.1590/s0102-311x2007000200002. Cad Saude Publica. 2007. PMID: 17221075 Review. Portuguese.
References
-
- Asian Development Bank. Cambodia and ADB 2023 [cited 2023 6/10/2023]. Available from: https://www.adb.org/countries/cambodia/overview#:∼:text=ADB's%20Work%20i....
-
- World Bank. Cambodia: Reducing Poverty and Sharing Prosperity October 29, 2019 [cited 2022 9th August 2022]. Available from: https://www.worldbank.org/en/results/2019/10/30/cambodia-reducing-povert....
-
- de Gaudemar M. Cambodia to remain among Least Developed Countries, for now. The Phnom Penh Post. 09 December 2016.
-
- Doha WTO Ministerial 2001: TRIPS WT/MIN(01)/DEC/2 20 November 2001, (Adopted on 14 November 2001).
-
- Kingdom of Camboida. HEALTH STRATEGIC PLAN 2016-2020 “Quality, Effective and Equitable Health Services”. In: Department of Planning & Health Information, editor. May 2016.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous